NSEDCP
SCMP

NJ State Employees Deferred Compensation Plan’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

NJ State Employees Deferred Compensation Plan’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-30,000
Closed -$539K – 502
2017
Q4 		$539K Buy
+30,000
New +$369K 0.09% 319

Other funds holding SCMP

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

NJ State Employees Deferred Compensation Plan's SCMP Position: Q1 2018 in Review

NJ State Employees Deferred Compensation Plan sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 30,000 shares — an estimated $539K sold.

NJ State Employees Deferred Compensation Plan first reported a position in SCMP in Q4 2017 and held it in 1 quarter. The position peaked at $539K in Q4 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

  • NJ State Employees Deferred Compensation Plan reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
  • NJ State Employees Deferred Compensation Plan sold 30,000 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $539K.
  • NJ State Employees Deferred Compensation Plan first reported a position in Sucampo Pharmaceuticals, Inc. in Q4 2017 and held it in 1 quarter.
  • NJ State Employees Deferred Compensation Plan's Sucampo Pharmaceuticals, Inc. position peaked at $539K in Q4 2017.
  • 3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q1 2018, filed 2 May 2018.